What was Dr Lal PathLabs’ Q2 FY26 net profit?
- Answer Field
-
The company reported a consolidated net profit of ₹152 crore in Q2 FY26.
Dr. Lal PathLabs is expected to post revenue of ₹ 730 Cr in Q2 FY26, up 11.2 % YoY. EBITDA is estimated at ₹ 218 Cr, a 7.8 % YoY increase, while PAT is projected at ₹ 151 Cr, marking 17 % YoY and 14.1 % QoQ growth.
Source: Bloomberg Estimates
Dr. Lal PathLabs Ltd. will announce its Q2 FY26 results on October 31, 2025, followed by a conference call at 4:30 PM. The quarter is expected to show sustained double-digit growth in revenue and profit, supported by steady demand for diagnostic services and a gradual normalization in operating costs.
Revenue for the quarter is estimated at ₹ 730 Cr, an increase of 11.2 % YoY and 9.6 % QoQ. Operating profit (EBITDA) is projected at ₹ 218 Cr, translating to 7.8 % YoY and 13.5 % sequential growth. Operating margins are expected at 29.7 %, compared with 30.7 % in Q2 FY25 and 28.7 % in Q1 FY26 a decline of 94 bps YoY but an improvement of 103 bps QoQ.
Net profit (PAT) is projected at ₹ 151 Cr, up 17 % from last year and 14.1 % from the previous quarter. This reflects a solid recovery in earnings aided by controlled expenditure and higher test volumes.
Particulars | Q2 FY26E | Q2 FY25 | YoY | Q1 FY26 | QoQ |
Revenue (₹ Bn) | 7.3 | 6.6 | 11.2 % | 6.70 | 9.6 % |
EBITDA (₹ Bn) | 2.18 | 2.0 | 7.8 % | 1.92 | 13.5 % |
EBITDA Margin (%) | 29.7 % | 30.7 % | -94 bps | 28.7 % | +103 bps |
PAT (₹ Cr) | 1.51 | 1.29 | 17.0 % | 1.32 | 14.1 % |
Dr. Lal PathLabs’ Q2 FY26 estimates highlight steady revenue growth and a notable increase in profitability. While margins remain slightly below the previous year’s levels, a sequential recovery signals operational efficiency improvement. The results announcement and management commentary on October 31 will offer greater clarity on demand trends, cost optimisation, and network expansion.
Disclaimer:
This content has been published for informational purposes only. Bajaj Broking is not affiliated with, nor does it endorse or assume any responsibility for, the source material. Readers are advised to consult the original publication for complete and accurate context.
No result found
The company reported a consolidated net profit of ₹152 crore in Q2 FY26.
Revenue from operations stood at ₹730 crore for the quarter ended 30 September 2025.
Yes. The Board declared a second interim dividend of ₹7 per equity share for FY26.
Yes. A 1:1 bonus issue was approved, subject to shareholder and regulatory approvals.
Revenue and profit both remained steady versus the same quarter last year, supported by marginal increase expenses and income volumes.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading